SwePub
Tyck till om SwePub Sök här!
Sök i LIBRIS databas

  Utökad sökning

db:Swepub
 

Sökning: db:Swepub > The spectrum of acu...

The spectrum of acute central nervous system symptoms during the treatment of childhood acute lymphoblastic leukaemia

Banerjee, Joanna (författare)
Helsinki Univ Hosp, Div Pediat Hematol & Oncol & Stem Cell Transplant, Helsinki, Finland.;Univ Helsinki, Helsinki, Finland.
Niinimäki, Riitta (författare)
Univ Oulu, Oulu Univ Hosp, Dept Children & Adolescents, Oulu, Finland.;Univ Oulu, PEDEGO Res Unit, Oulu, Finland.
Lähteenmäki, Päivi (författare)
Karolinska Institutet
visa fler...
Myrberg, Ida Hed (författare)
Karolinska Institutet
Arola, Mikko (författare)
Tampere Univ Hosp, Dept Pediat, Tampere, Finland.;Kuopio Univ Hosp, Dept Pediat, Kuopio, Finland.
Riikonen, Pekka (författare)
Kuopio Univ Hosp, Dept Pediat, Kuopio, Finland.
Lönnqvist, Tuula (författare)
Univ Helsinki, Helsinki, Finland.;Helsinki Univ Hosp, Div Child Neurol, Helsinki, Finland.
Palomäki, Maarit (författare)
Helsinki Univ Hosp, Dept Radiol, Helsinki Med Imaging Ctr, Helsinki, Finland.
Ranta, Susanna (författare)
Karolinska Institutet
Harila-Saari, Arja H. (författare)
Uppsala universitet,Barnneurologi/Barnonkologi
Taskinen, Mervi (författare)
Helsinki Univ Hosp, Div Pediat Hematol & Oncol & Stem Cell Transplant, Helsinki, Finland.;Univ Helsinki, Helsinki, Finland.
visa färre...
Helsinki Univ Hosp, Div Pediat Hematol & Oncol & Stem Cell Transplant, Helsinki, Finland;Univ Helsinki, Helsinki, Finland. Univ Oulu, Oulu Univ Hosp, Dept Children & Adolescents, Oulu, Finland.;Univ Oulu, PEDEGO Res Unit, Oulu, Finland. (creator_code:org_t)
2019-11
2020
Engelska.
Ingår i: Pediatric Blood & Cancer. - : WILEY. - 1545-5009 .- 1545-5017. ; 67:2
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Background: Children with central nervous system (CNS) toxicity during therapy for acute lymphoblastic leukaemia (ALL) are at risk for treatment modifications, long-term sequelae and even higher mortality. A better understanding of CNS symptoms and their complications improves the potential to prevent and treat them.Methods: Patient files from 649 children treated with Nordic Society of Pediatric Hematology and Oncology ALL92 and ALL2000 protocols in Finland were reviewed retrospectively for any acute CNS symptom. Detailed data on symptoms, examinations and treatment of the underlying CNS complications were collected from the medical records. Disease-related and outcome data were retrieved from the Nordic leukaemia registry.Results: Altogether, 13% (86) of patients with ALL had acute CNS symptoms. Most symptoms (64%) occurred during the first 2 months of therapy. Posterior reversible encephalopathy syndrome was the most frequent complication (4.5%). Cerebrovascular events were diagnosed in 10 cases (1.6%), while methotrexate-related stroke-like syndrome (SLS) was observed in only one patient (0.2%). CNS symptoms due to systemic or unclear conditions, especially sepsis, were important for differential diagnosis. CNS leukaemia was associated with CNS symptoms (hazard ratio [HR] = 4.03; P = .003), and epilepsy was a common sequel of CNS complications (19%).Conclusions: Acute CNS symptoms are common during ALL therapy, occurring mainly during the first 2 months of treatment. Patients with CNS leukaemia at diagnosis are at a higher risk for CNS toxicity. Despite intensive CNS-directed methotrexate treatment, SLS was diagnosed extremely rarely in our series.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Hematologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Hematology (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Pediatrik (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Pediatrics (hsv//eng)

Nyckelord

acute lymphoblastic leukaemia
children
neurotoxicity
outcome
posterior reversible encephalopathy syndrome
sinovenous thrombosis
stroke-like syndrome

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy